Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Repurchased
Ratios

Haemonetics (HAE) Shares Issued (2016 - 2025)

Historic Shares Issued for Haemonetics (HAE) over the last 17 years, with Q4 2025 value amounting to $1.1 million.

  • Haemonetics' Shares Issued rose 12712.87% to $1.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $2.2 million, marking a year-over-year increase of 1948.41%. This contributed to the annual value of $1.6 million for FY2024, which is 3896.89% down from last year.
  • Latest data reveals that Haemonetics reported Shares Issued of $1.1 million as of Q4 2025, which was up 12712.87% from $63000.0 recorded in Q3 2025.
  • Over the past 5 years, Haemonetics' Shares Issued peaked at $2.4 million during Q2 2021, and registered a low of $63000.0 during Q3 2025.
  • Over the past 5 years, Haemonetics' median Shares Issued value was $462000.0 (recorded in 2025), while the average stood at $650210.5.
  • In the last 5 years, Haemonetics' Shares Issued surged by 151969.7% in 2021 and then plummeted by 8627.37% in 2022.
  • Haemonetics' Shares Issued (Quarter) stood at $1.1 million in 2021, then crashed by 85.03% to $160000.0 in 2022, then grew by 16.25% to $186000.0 in 2023, then soared by 171.51% to $505000.0 in 2024, then surged by 127.13% to $1.1 million in 2025.
  • Its last three reported values are $1.1 million in Q4 2025, $63000.0 for Q3 2025, and $462000.0 during Q2 2025.